MedPath

Testo-100

Testo-100

Approved
Approval ID

593ebdf5-54c6-7fae-e053-2991aa0a8e4a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 4, 2023

Manufacturers
FDA

Advanced Pharmaceutical Technology, Inc.

DUNS: 023237884

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Testosterone,USP

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code57377-100
Product Classification
G
Generic Name
Testosterone,USP
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateNovember 4, 2023
FDA Product Classification

INGREDIENTS (3)

POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
TESTOSTERONEActive
Quantity: 100 mg in 1 1
Code: 3XMK78S47O
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Testo-100 - FDA Drug Approval Details